Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Candore

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Current Pharmaceutical Design|November 11, 2008
A scientific approach to anti-ageing therapies: state of the artE Jirillo, G Candore, T Magrone, et al.
Cancer Gene Therapy|January 11, 2014
Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatmentsC R Balistreri, G Candore, D Lio, et al.
European Journal of Cell Biology|December 24, 1997
Phenoloxidase-dependent cytotoxic mechanism in ascidian (Styela plicata) hemocytes active against erythrocytes and K562 tumor cellsM Cammarata, V Arizza, N Parrinello, et al.
Current Pharmaceutical Design|April 15, 2010
Low grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for anti-ageing strategies and successful ageing achievementG Candore, C Caruso, E Jirillo, et al.
Immunopharmacology and Immunotoxicology|January 1, 1991
HLA-B8,DR3 T cell impairment is completely restored by in vitro treatment with interleukin-2G Candore, A T Colucci, M A Modica, et al.
Immunobiology|November 1, 1990
Markers of T lymphocyte activation in HLA-B8, DR3 positive individualsM A Modica, A M Zambito, G Candore, et al.
Current Pharmaceutical Design|November 11, 2008
Polyphenols from red wine modulate immune responsiveness: biological and clinical significanceT Magrone, G Candore, C Caruso, et al.
HLA|June 8, 2018
Autoimmune diseases and 8.1 ancestral haplotype: An updateC M Gambino, A Aiello, G Accardi, et al.
Disease Markers|March 1, 1992
IgD serum levels are influenced by HLA-DR phenotypeD Lio, G Candore, A T Colucci, et al.
Experimental and Clinical Immunogenetics|January 1, 1994
Viral antibody titers are influenced by HLA-DR2 phenotypeD Lio, N Caccamo, C D'Anna, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Current Pharmaceutical Design|November 11, 2008
A scientific approach to anti-ageing therapies: state of the artE Jirillo, G Candore, T Magrone, et al.
Cancer Gene Therapy|January 11, 2014
Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatmentsC R Balistreri, G Candore, D Lio, et al.
European Journal of Cell Biology|December 24, 1997
Phenoloxidase-dependent cytotoxic mechanism in ascidian (Styela plicata) hemocytes active against erythrocytes and K562 tumor cellsM Cammarata, V Arizza, N Parrinello, et al.
Current Pharmaceutical Design|April 15, 2010
Low grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for anti-ageing strategies and successful ageing achievementG Candore, C Caruso, E Jirillo, et al.
Immunopharmacology and Immunotoxicology|January 1, 1991
HLA-B8,DR3 T cell impairment is completely restored by in vitro treatment with interleukin-2G Candore, A T Colucci, M A Modica, et al.
Immunobiology|November 1, 1990
Markers of T lymphocyte activation in HLA-B8, DR3 positive individualsM A Modica, A M Zambito, G Candore, et al.
Current Pharmaceutical Design|November 11, 2008
Polyphenols from red wine modulate immune responsiveness: biological and clinical significanceT Magrone, G Candore, C Caruso, et al.
HLA|June 8, 2018
Autoimmune diseases and 8.1 ancestral haplotype: An updateC M Gambino, A Aiello, G Accardi, et al.
Disease Markers|March 1, 1992
IgD serum levels are influenced by HLA-DR phenotypeD Lio, G Candore, A T Colucci, et al.
Experimental and Clinical Immunogenetics|January 1, 1994
Viral antibody titers are influenced by HLA-DR2 phenotypeD Lio, N Caccamo, C D'Anna, et al.
Pageof 8